Page last updated: 2024-10-26

edrophonium and Granuloma, Plasma Cell, Orbital

edrophonium has been researched along with Granuloma, Plasma Cell, Orbital in 1 studies

Edrophonium: A rapid-onset, short-acting cholinesterase inhibitor used in cardiac arrhythmias and in the diagnosis of myasthenia gravis. It has also been used as an antidote to curare principles.
edrophonium : A quaternary ammonium ion that is N-ethyl-N,N-dimethylanilinium in which one of the meta positions is substituted by a hydroxy group. It is a reversible inhibitor of cholinesterase, with a rapid onset (30-60 seconds after injection) but a short duration of action (5-15 minutes). The chloride salt is used in myasthenia gravis both diagnostically and to distinguish between under- or over-treatment with other anticholinesterases. It has also been used for the reversal of neuromuscular blockade in anaesthesia, and for the management of poisoning due to tetrodotoxin, a neuromuscular blocking toxin found in puffer fish and other marine animals.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Fujita, S1
Furuta, N1
Maruyama, T1
Tsukagoshi, S1
Nagashima, K1
Fujita, Y1
Nagai, K1
Kashima, T1
Tanaka, M1
Miki, I1
Yamazaki, A1
Ikota, H1
Oyama, T1
Ikeda, Y1

Other Studies

1 other study available for edrophonium and Granuloma, Plasma Cell, Orbital

ArticleYear
Idiopathic Orbital Inflammation Appearing on the Affected Side of Preceding Myasthenia Gravis.
    Internal medicine (Tokyo, Japan), 2020, Volume: 59, Issue:14

    Topics: Aged; Biopsy; Brain; Edrophonium; Humans; Immunoglobulin G; Magnetic Resonance Imaging; Male; Myasth

2020